Ledger.Open graph →
SEC Form D · filed January 26, 2016

Aequus Pharmaceuticals Inc

Offering
$629K
Sold
$629K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Fotios Plakogiannis · Vancouver, British Columbia, CanadaDirectorHamed Shahbazi · Vancouver, British Columbia, CanadaDirectorIan Ball · Vancouver, British Columbia, CanadaExecRodoula Plakogiannis · Vancouver, British Columbia, CanadaDirectorJason Flowerday · Vancouver, British Columbia, CanadaDirectorAnne Stevens · Vancouver, British Columbia, CanadaExec · DirectorDoug Janzen · RICHMOND, British Columbia, CanadaExec · DirectorDonald Mcafee · Vancouver, British Columbia, CanadaExecChristina Yip · Vancouver, British Columbia, CanadaExecChris Clark · Vancouver, British Columbia, CanadaDirectorHamed Shahbazi · Burnaby, British Columbia, CanadaDirectorRodoula Plakogiannis · Vancouver, British Columbia, CanadaDirectorFotios Plakogiannis · Vancouver, British Columbia, CanadaDirectorJason Flowerday · Vancouver, British Columbia, CanadaDirectorAnne Stevens · Vancouver, British Columbia, CanadaExec · DirectorDoug Janzen · Vancouver, British Columbia, CanadaExec · DirectorDonald Mcafee · Vancouver, British Columbia, CanadaExecChristina Yip · Vancouver, British Columbia, CanadaExecChris Clark · Colorado Springs, CODirectorHamed Shahbazi · Vancouver, British Columbia, CanadaDirectorIan Ball · Vancouver, British Columbia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗